Dr. Jay Short

Dr. Short is the founder of BioAtla, LLC, a pioneering biological services company, and currently serves as its Chairman and CEO.   He is also a founder of Diversa Corporation (now Verenium) where he served in multiple roles over his 11 year tenure, which concluded in 2005, including CEO, President and Chief Technology Officer.  Dr. Short led the company in raising a combined $500 million by leading the largest biotechnology IPO at the time and establishing partnerships and joint ventures with best-in-class companies including Novartis, Syngenta, Dow Chemical, Dupont, Bunge, Danisco, GSK, Merck and Aventis.  Dr. Short received San Diego's 2001 Ernst & Young Entrepreneur of the Year Award in Health Sciences and has authored more than 100 publications.  He is named inventor of over 100 issued patents and several hundred pending patents. He has served on the U.S. National Research Council panel for Chemical Science and Technology at the National Institute of Standards and Technology and numerous other governmental, grant and journal review committees and boards.